GSDMD and systemic lupus erythematosus: As GSDMD-deficient mice exhibited impaired SLE pathogenesis, we sought to test whether the pharmacological inhibition of GSDMD was sufficient to achieve a similar degree of disease remission in the MRL/lpr mice.